TIDMINS

RNS Number : 5426F

Instem plc

18 May 2017

Instem plc

("Instem")

Result of Annual General Meeting

Instem plc (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that at its Annual General Meeting, held today, all resolutions were duly passed.

For further information, please contact:

 
 Instem plc                 +44 (0) 1785 825 600 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 
   N+1 Singer (Nominated 
   Adviser & Broker)          +44 (0) 20 7496 3000 
 Richard Lindley 
  Nick Owen 
  James White 
 
 
   Walbrook Financial PR      +44 (0) 20 7933 8780 
 Paul Cornelius             instem@walbrookpr.com 
 Helen Cresswell 
  Sam Allen 
  Paul Whittington

About Instem

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit www.instem.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSFDSUAFWSEEI

(END) Dow Jones Newswires

May 18, 2017 05:24 ET (09:24 GMT)

Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Instem Charts.
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Instem Charts.